₹262
(Inclusive of all Taxes)
₹39.3 Cashback (15%)
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
Composition :
ETODOLAC-400MG + THIOCOLCHICOSIDE-4MG
Manufacturer/Marketer :
Akumentis Healthcare Ltd
Consume Type :
ORAL
Return Policy :
Not Returnable
Expires on or after :
Drug-Drug Interactions
Drug-Drug Interactions
Login/Sign Up
How does the drug interact with Etorite-MR 4 mg Tablet:
Co-administration of Etorite-MR 4 mg Tablet with Meloxicam can raise the adverse consequences in the digestive system, including inflammation, bleeding, ulceration, and, in rare cases, perforation(rupture).
How to manage the interaction:
Taking Meloxicam with Etorite-MR 4 mg Tablet is not recommended can result in an interaction, it can be taken if a doctor has advised it. If you notice any of these symptoms like dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness consult a doctor. Do not discontinue any medications without consulting a doctor.
Co-administration of Etorite-MR 4 mg Tablet with Meloxicam can raise the adverse consequences in the digestive system, including inflammation, bleeding, ulceration, and, in rare cases, perforation(rupture).
How to manage the interaction:
Taking Meloxicam with Etorite-MR 4 mg Tablet is not recommended can result in an interaction, it can be taken if a doctor has advised it. If you notice any of these symptoms like dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness consult a doctor. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Etorite-MR 4 mg Tablet:
Using ketorolac together with Etorite-MR 4 mg Tablet may increase the risk of side effects in the gastrointestinal tract (inflammation, bleeding and ulceration).
How to manage the interaction:
Taking Etorite-MR 4 mg Tablet with Ketorolac is not recommended, but it can be taken together if prescribed by a doctor. However, if you experience unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult a doctor immediately. Do not discontinue any medications without consulting a doctor.
Using ketorolac together with Etorite-MR 4 mg Tablet may increase the risk of side effects in the gastrointestinal tract (inflammation, bleeding and ulceration).
How to manage the interaction:
Taking Etorite-MR 4 mg Tablet with Ketorolac is not recommended, but it can be taken together if prescribed by a doctor. However, if you experience unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult a doctor immediately. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Etorite-MR 4 mg Tablet:
Taking Human immunoglobulin with Etorite-MR 4 mg Tablet, may raise the risk of kidney problems.
How to manage the interaction:
Although taking Human immunoglobulin and Etorite-MR 4 mg Tablet together can cause an interaction, it can be taken if a doctor has suggested it. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
Taking Human immunoglobulin with Etorite-MR 4 mg Tablet, may raise the risk of kidney problems.
How to manage the interaction:
Although taking Human immunoglobulin and Etorite-MR 4 mg Tablet together can cause an interaction, it can be taken if a doctor has suggested it. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
EtodolacValdecoxib
Severe
How does the drug interact with Etorite-MR 4 mg Tablet:
When valdecoxib is used with Etorite-MR 4 mg Tablet, there is an increased risk of significant gastrointestinal toxicity (inflammation, bleeding, ulceration, and perforation).
How to manage the interaction:
Although taking Etorite-MR 4 mg Tablet and Valdecoxib together can cause an interaction, it can be taken if a doctor has suggested it. If you're having any of these symptoms like stomach problems, inflammation, bleeding, or ulcers, it's important to let a doctor know right away. Do not discontinue any medications without consulting a doctor.
When valdecoxib is used with Etorite-MR 4 mg Tablet, there is an increased risk of significant gastrointestinal toxicity (inflammation, bleeding, ulceration, and perforation).
How to manage the interaction:
Although taking Etorite-MR 4 mg Tablet and Valdecoxib together can cause an interaction, it can be taken if a doctor has suggested it. If you're having any of these symptoms like stomach problems, inflammation, bleeding, or ulcers, it's important to let a doctor know right away. Do not discontinue any medications without consulting a doctor.
EtodolacRofecoxib
Severe
How does the drug interact with Etorite-MR 4 mg Tablet:
Taking Rofecoxib with Etorite-MR 4 mg Tablet may raise the risk of gastrointestinal adverse effects (inflammation, bleeding, ulceration, and, in rare cases perforation).
How to manage the interaction:
Co-administration of Etorite-MR 4 mg Tablet with Rofecoxib can result in an interaction, but it can be taken if a doctor has advised it. Do not stop using any medications without a doctor's advice.
Taking Rofecoxib with Etorite-MR 4 mg Tablet may raise the risk of gastrointestinal adverse effects (inflammation, bleeding, ulceration, and, in rare cases perforation).
How to manage the interaction:
Co-administration of Etorite-MR 4 mg Tablet with Rofecoxib can result in an interaction, but it can be taken if a doctor has advised it. Do not stop using any medications without a doctor's advice.
How does the drug interact with Etorite-MR 4 mg Tablet:
When tolmetin is used with Etorite-MR 4 mg Tablet, there is an increased risk of significant gastrointestinal toxicity (inflammation, bleeding, ulceration, and perforation).
How to manage the interaction:
Taking Etorite-MR 4 mg Tablet with Tolmetin together can result in an interaction, but it can be taken if a doctor has advised it. However, if you experience unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult the doctor. Do not stop using any medications without a doctor's advice.
When tolmetin is used with Etorite-MR 4 mg Tablet, there is an increased risk of significant gastrointestinal toxicity (inflammation, bleeding, ulceration, and perforation).
How to manage the interaction:
Taking Etorite-MR 4 mg Tablet with Tolmetin together can result in an interaction, but it can be taken if a doctor has advised it. However, if you experience unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult the doctor. Do not stop using any medications without a doctor's advice.
EtodolacTinzaparin
Severe
How does the drug interact with Etorite-MR 4 mg Tablet:
Use of tinzaparin with Etorite-MR 4 mg Tablet may raise the risk of bleeding problems.
How to manage the interaction:
There may be a possibility of interaction between Etorite-MR 4 mg Tablet and Tinzaparin, but it can be taken if prescribed by a doctor. However, if you experience unusual bleeding or bruising, swelling, vomiting, blood in your urine or stools, headache, dizziness, or weakness while taking these drugs, consult doctor immediately. Do not discontinue any medications without consulting a doctor.
Use of tinzaparin with Etorite-MR 4 mg Tablet may raise the risk of bleeding problems.
How to manage the interaction:
There may be a possibility of interaction between Etorite-MR 4 mg Tablet and Tinzaparin, but it can be taken if prescribed by a doctor. However, if you experience unusual bleeding or bruising, swelling, vomiting, blood in your urine or stools, headache, dizziness, or weakness while taking these drugs, consult doctor immediately. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Etorite-MR 4 mg Tablet:
Coadministration of Etorite-MR 4 mg Tablet with cidofovir can increase the risk of kidney damage.
How to manage the interaction:
Although taking Etorite-MR 4 mg Tablet and cidofovir together can cause an interaction, it can be taken if a doctor has suggested it. However, if you experience nausea, vomiting, loss of hunger, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
Coadministration of Etorite-MR 4 mg Tablet with cidofovir can increase the risk of kidney damage.
How to manage the interaction:
Although taking Etorite-MR 4 mg Tablet and cidofovir together can cause an interaction, it can be taken if a doctor has suggested it. However, if you experience nausea, vomiting, loss of hunger, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
EtodolacIbritumomab tiuxetan (90y)
Severe
How does the drug interact with Etorite-MR 4 mg Tablet:
Taking Ibritumomab tiuxetan (90y) with Etorite-MR 4 mg Tablet may increase the risk of bleeding and severe hemorrhage.
How to manage the interaction:
Although there is a possible interaction between Etorite-MR 4 mg Tablet and Ibritumomab tiuxetan (90y), you can take these medicines together if prescribed by a doctor. However, if you experience any unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, a severe headache, and/or weakness, consult a doctor immediately. Do not discontinue any medications without consulting a doctor.
Taking Ibritumomab tiuxetan (90y) with Etorite-MR 4 mg Tablet may increase the risk of bleeding and severe hemorrhage.
How to manage the interaction:
Although there is a possible interaction between Etorite-MR 4 mg Tablet and Ibritumomab tiuxetan (90y), you can take these medicines together if prescribed by a doctor. However, if you experience any unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, a severe headache, and/or weakness, consult a doctor immediately. Do not discontinue any medications without consulting a doctor.
EtodolacMetrizamide
Severe
How does the drug interact with Etorite-MR 4 mg Tablet:
Taking Etorite-MR 4 mg Tablet and Metrizamide can increase the risk of kidney damage.
How to manage the interaction:
There may be a possibility of interaction between Etorite-MR 4 mg Tablet and Metrizamide, but it can be taken if prescribed by a doctor. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor immediately. Drink lots of fluid after the surgery to stay hydrated and to flush the contrast agent out of your kidneys. Do not stop using any medications without talking to a doctor.
Taking Etorite-MR 4 mg Tablet and Metrizamide can increase the risk of kidney damage.
How to manage the interaction:
There may be a possibility of interaction between Etorite-MR 4 mg Tablet and Metrizamide, but it can be taken if prescribed by a doctor. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor immediately. Drink lots of fluid after the surgery to stay hydrated and to flush the contrast agent out of your kidneys. Do not stop using any medications without talking to a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Product Substitutes
Alcohol
Unsafe
Avoid consumption of alcohol while taking Etorite-Mr 4mg Tablet as it may cause increased drowsiness. It can also increase the risk of stomach bleeding.
Pregnancy
Caution
Please consult your doctor if you are pregnant; your doctor will prescribe only if the benefits outweigh the risks.
Breast Feeding
Caution
Please consult your doctor if you are breastfeeding; your doctor will decide whether Etorite-Mr 4mg Tablet can be taken by breastfeeding mothers or not.
Driving
Caution
Etorite-Mr 4mg Tablet may cause dizziness and drowsiness. Do not drive or operate machinery unless you are alert.
Liver
Caution
Dose adjustment may be needed in patients with liver impairment. Please consult your doctor if you have liver problems or any concerns regarding this.
Kidney
Caution
Dose adjustment may be needed in patients with kidney impairment. Please consult your doctor if you have kidney problems or any concerns regarding this.
Children
Unsafe
Etorite-Mr 4mg Tablet is not recommended for children as the safety and effectiveness were not established.
Have a query?
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
